Price loading...

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in the United States

Price data last checked 92 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in India
98% match

The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in India

£515.00 21 Jan 2026
The 2023-2028 Outlook for Bone Marrow Transplants in the United States
98% match

The 2023-2028 Outlook for Bone Marrow Transplants in the United States

£520.00 14 Jan 2026
The 2023-2028 World Outlook for Bone Marrow Autologous Cell Therapies
98% match

The 2023-2028 World Outlook for Bone Marrow Autologous Cell Therapies

Out of Stock 25 Jan 2026
The 2023-2028 Outlook for Bone Marrow Transplants in India
97% match

The 2023-2028 Outlook for Bone Marrow Transplants in India

£515.00 23 Jan 2026
The 2023-2028 Outlook for Bone Growth Stimulators in the United States
96% match

The 2023-2028 Outlook for Bone Growth Stimulators in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Cell Culture in Healthcare in the United States
96% match

The 2023-2028 Outlook for Cell Culture in Healthcare in the United States

£520.00 20 Apr 2026
The 2023-2028 Outlook for Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Lymphoma Treatments in the United States

£520.00 29 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in the United States

£520.00 26 Feb 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
96% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Erythropoietin Drugs in the United States
96% match

The 2023-2028 Outlook for Erythropoietin Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States

£520.00 21 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Osteoporosis Treatments in the United States
96% match

The 2023-2028 Outlook for Osteoporosis Treatments in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Cellulite Treatments in the United States
96% match

The 2023-2028 Outlook for Cellulite Treatments in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States
96% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in the United States
96% match

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Autism Therapies in the United States
96% match

The 2023-2028 Outlook for Autism Therapies in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Autism Spectrum Disorder Therapeutics in the United States
96% match

The 2023-2028 Outlook for Autism Spectrum Disorder Therapeutics in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026